Cargando…
A Review of Translational Research for Targeted Therapy for Metastatic Colorectal Cancer
SIMPLE SUMMARY: Colorectal cancer is the third most common cause of cancer-related death in the United States with 20% of patients presenting with metastatic disease at time of diagnosis. Metastatic colon cancer is often treated with a combination of surgery, systemic therapy, and/or regional therap...
Autores principales: | Ruff, Samantha M., Pawlik, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000872/ https://www.ncbi.nlm.nih.gov/pubmed/36900187 http://dx.doi.org/10.3390/cancers15051395 |
Ejemplares similares
-
The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis
por: Ruff, Samantha M., et al.
Publicado: (2023) -
Advances in Targeted Immunotherapy for Hepatobiliary Cancers
por: Ruff, Samantha M., et al.
Publicado: (2022) -
Current Targeted Therapy for Metastatic Colorectal Cancer
por: Ohishi, Tomokazu, et al.
Publicado: (2023) -
Role of targeted therapy in metastatic colorectal cancer
por: Ohhara, Yoshihito, et al.
Publicado: (2016) -
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Ruff, Samantha M., et al.
Publicado: (2023)